Otsuka Holdings, Japan's largest unlisted drug company by sales, is weighing an initial public offering and may hire Nomura Holdings and UBS as underwriters, bankers familiar with the situation told Bloomberg News.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment